Judit Peix
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
E7386 Enhances Lenvatinib's Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 25, 2025
Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC.
Journal: JHEP reports : innovation in hepatology
Published: April 05, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma.
Journal: Journal of hepatology
Published: February 02, 2024
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Journal: Molecular cancer therapeutics
Published: May 11, 2022
Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878].
Journal: Journal of hepatology
Published: October 10, 2021
Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 12, 2021
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
Journal: Journal of hepatology
Published: November 30, 2020
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: November 25, 2020
DNA Methylation Profiling of Human Hepatocarcinogenesis.
Journal: Hepatology (Baltimore, Md.)
Published: July 19, 2020
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.
Journal: Journal of hepatology
Published: September 30, 2019
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.
Journal: British journal of cancer
Published: April 15, 2019
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Journal: Gastroenterology
Published: January 28, 2019
Last Updated: 09/26/2026